Advertisement
Should we focus on the sugar or the weight?
Post-hoc analysis follows from STAMPEDE trial
1-Minute Consult
There is a need for ongoing monitoring
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New findings presented at ACS Clinical Congress 2017
Glycation lowers ApoA1 stability, destroys HDL in T2DM
A patient’s answer ‘changed everything’
Benefits even those with severe type 2 diabetes
Aids with three crucial clinical questions
Referring patients early is key
Advertisement
Advertisement